Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
License revenue - related party	$ 924	$ 1,173	$ 2,369	$ 5,242
Operating expenses:
Research and development	7,960	7,218	24,060	19,548
General and administrative	8,723	2,209	13,527	4,706
Total operating expenses	16,683	9,427	37,587	24,254
Loss from operations	(15,759)	(8,254)	(35,218)	(19,012)
Other income/(expense):
Interest income	1,027	416	2,320	505
(Loss)/gain on currency exchange, net	(16)	56	(53)	156
Other expense	(15)	(2)	(41)	(9)
Total other income	996	470	2,226	652
Net loss	$ (14,763)	$ (7,784)	$ (32,992)	$ (18,360)
Net loss per share attributable to common stockholders, basic	$ (3.78)	$ (8.9)	$ (17.4)	$ (21)
Net loss per share attributable to common stockholders, diluted	$ (3.78)	$ (8.9)	$ (17.4)	$ (21)
Weighted-average number of common shares outstanding, used in computing net loss per common share, basic	3,906,886	874,327	1,896,605	874,138
Weighted-average number of common shares outstanding, used in computing net loss per common share, diluted	3,906,886	874,327	1,896,605	874,138
Comprehensive loss:
Net loss	$ (14,763)	$ (7,784)	$ (32,992)	$ (18,360)
Other comprehensive income/(loss):
Change in unrealized losses related to available-for-sale debt securities	15	(150)	157	(150)
Total other comprehensive income/(loss)	15	(150)	157	(150)
Total comprehensive loss	$ (14,748)	$ (7,934)	$ (32,835)	$ (18,510)